创新医疗子公司博灵脑机产品临床试验进展引关注

Group 1 - The core focus of the news is on the developments of the subsidiary, Boling Brain Machine, particularly its B-end product, Cyberlink AM5, which is currently undergoing multi-center clinical trials [1] - If the clinical trials progress smoothly, the company expects to complete the registration application for Class II medical devices by the first half of 2026 [1] - This event may significantly impact the company's technological commercialization process [1]